dual gip glp 1 receptor agonists and Triple Gut Peptide on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Effects of tirzepatide, a dual
Description
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been studied for their cardiovascular benefits in type 2 diabetes
Mechanistic hypotheses include reduced leptin-driven T-helper (Th)1/Th17 activity, improved adipokine balance, and modulation of gut-thyroid axis pathways
Berberine patches reviewed: what science says about effectiveness, how they compare to oral supplements, side effects, and safety guidance.
The airball comes as Novo scrambles to regain a majority share of the GLP-1 market.
